A randomized trial com- paring activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med. 1994;154(1):49-56. 89. Whit eld LR, Lele AS, Levy G. Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin. Clin Pharmacol Ther. 1983;34(1):23-28. 90. Edson JR, Krivit W, White JG. Kaolin partial thrombo- plastin time: high levels of procoagulants producing short clotting times or masking de ciencies of other procoagulants or low concentrations of anticoagulants. J Lab Clin Med. 1967;70(3):463-470. 91. Becker RC, Corrao JM, Bovill EG, et al. Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormality. Am Heart J. 1990;119(6): 1254-1261. 92. Fisher AR, Bailey CR, Shannon CN, Wielogorski AK. Heparin resistance after aprotinin. Lancet. 1992;340(8829):1230-1231. 93. Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Stroke prevention in nonvalvular atrial brilla- tion. Ann Intern Med. 1991;115(9):727-736. 94. Blossom DB, Kallen AJ, Patel PR, et al. Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med. 2008;359(25):2674-2684. 95. Li B, Suwan J, Martin JG, et al. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins. Biochem Pharmacol. 2009;78(3):292-300. 96. Carlson MK, Gleason PP, Sen S. Elevation of hepatic trans- aminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity. Pharmacotherapy. 2001;21(1):108-113. 97. Warkentin TE, Kelton JG. A 14-year study of heparin- induced thrombocytopenia. Am J Med. 1996;101(5): 502-507. 98. Rajgopal R, Butcher M, Weitz JI, Shaughnessy SG. Heparin synergistically enhances interleukin-11 signaling through up-regulation of the MAPK pathway. J Biol Chem. 2006;281(30):20780-20787. 99. American Society of Heath-system Pharmacists. Protamine Sulfate: Antiheparin Agents. Bethesda, MD: American Society of Health-system Pharmacists; 1999. 100. Caplan SN, Berkman EM. Letter: Protamine sulfate and sh allergy. 